Skip to main content
. 2021 Mar 15;28(11):6696–6704. doi: 10.1245/s10434-021-09744-y

Table 3.

Site of disease recurrence

Localization of disease recurrence Total (n = 70 patients), 30 recurrences [42.9%] Node-negative pelvis (n = 43 patients), 17 recurrences [39.5%] Node-positive pelvis (n = 14 patients), 8 recurrences (57.1%) Pelvic status unknown (n = 13), 5 recurrences (38.5%)
No recurrence 32 (45.7) 22 (51.2) 4 (28.6) 6 (46.2)
Vulva only 15 (21.4) 10 (23.3) 3 (21.4) 2 (15.4)
Groin only 1 (1.4) 1 (2.3) 0 0
Vulva + groin 3 (4.3) 0 1 (7.1) 2 (15.4)
Pelvis (± other localizations) 4 (5.7) 3 (7) 0 1 (7.7)
Distant (± other localizations) 7 (10) 3 (7) 4 (28.6) 0
Death before recurrence 8 (11.4) 4 (9.3) 2 (14.3) 2 (15.4)

Data are expressed as n (%)